Morphinan-6-one,4,5-epoxy-14-hydroxy-3- methoxy-17-methyl-,hydrochloride,(5R)-,mixt. with (RS)-R-[(1R)-1-(methylamino)ethyl]- benzenemethanol hydrochloride and (1R,2â,4â,5R,7â)-9-methyl-3-oxa-9- azatricyclo[3.3.1.02,4]non-7-yl (RS)-R-(hydroxymethyl)benzeneacetate hydrobromide (65505-28-4)

Other Product

• Benzeneacetic acid,R-(hydroxymethyl)-,(1R,2â,- 4â,5R,7â)-9-methyl-3-oxa-9-azatricyclo- [3.3.1.02,4]non-7-yl ester,(RS)-,hydrobromide,mixt. with 3,7-dihydro-1,3,7-trimethyl-1Hpurine- 2,6-dione,N,N-dimethyl-ç-phenyl-2- pyridinepropanamine (2Z)-2-butenedioate (1:1) and ethyl 4-aminobenzoate
• 3-Oxa-9-azoniatricyclo[3.3.1.02,4]nonane,9- butyl-7-[(2S)-3-hydroxy-1-oxo-2-phenylpropoxy]- 9-methyl-,bromide,(1R,2â,4â,5R,7â)-,mixt. with 3,6-dihydro-R-[(2-methylphenoxy)methyl]-1- (2H)-pyridineethanol hydrochloride and 3-methylbutyl R-[[2-(diethylamino)ethyl]amino]- benzeneacetate dihydrochloride
• 1(3H)-Isobenzofuranone,6,7-dimethoxy-3- [(5R)-5,6,7,8-tetrahydro-4-methoxy-6- methyl-1,3-dioxolo[4,5-g]isoquinolin-5-yl]-,hydrochloride,(3S)-,mixt. with rel-(RS)-R-[(1R)-1-(dimethylamino)ethyl]- benzenemethanol hydrochloride and 2-(diphenylmethoxy)-N,N-dimethylethanamine hydrochloride
• Morphinan-6-ol, 7,8-didehydro-4,5-epoxy-3-ethoxy-17-methyl-, hydrochloride, (5alpha,6alpha)-, mixt. with (7(S)-(1alpha,2beta,4beta,5alpha,7beta))-9-methyl-3-oxa-9-azatricyclo(3.3.1.0(2,4))non-7-yl alpha-(hydroxymethyl)benzeneacetate hydrobromide and sodium (1S)-7,7-dimethyl-2-oxobicyclo(2.2.1)heptane-1-methane sulfonate
• Morphinan,3-methoxy-17-methyl-,hydrobromide,(9R,13R,14R)-,mixt. with rel-(RS)-R-[(1R)-1-aminoethyl]- benzenemethanol hydrochloride,ç-(4-chlorophenyl)-N,N-dimethyl-2- pyridinepropanamine (2Z)-2-butenedioate (1:1) and N-(4-hydroxyphenyl)acetamide
• 3-Oxa-9-azoniatricyclo[3.3.1.02,4]nonane,9- butyl-9-methyl-7-[(1-oxo-2-phenyl-2- propenyl)oxy]-,bromide,(1R,2â,4â,5R,7â)-
• Benzo[3,4]-18-norandrosta-3,12,15-trien-17- one,6'-ethyl-1',2',3',4',5',6'-hexahydro-7- hydroxy-4,6',8-trimethyl-,(3â,4R,6'R,7â,8R,9â,- 10R,14â)-
• Aspidospermidine-15-acetic acid,4-(acetyloxy)-6,7-didehydro-R-[(RS)- [(3R,5S)-5-ethyl-5-hydroxy-1-methyl-3- piperidinyl]methyl]-3-hydroxy-16-methoxy-3- (methoxycarbonyl)-1-methyl-R-(3-methyl- 1H-indol-2-yl)-,methyl ester,(2â,3â,4â,5R,12â,19R)-
• 2,5-Cyclohexadiene-1-butanoic acid,4-amino-R-[[(2S)-3-methyl-2-(methylamino)- 1-oxobutyl]amino]-,(RS,1R,4â)-
• Acetamide,N-(4-hydroxyphenyl)-,mixt. with rel-(RS)-R-[(1R)-1-aminoethyl]- benzenemethanol hydrochloride and (3S)-6,7-dimethoxy-3-[(5R)-5,6,7,8-tetrahydro- 4-methoxy-6-methyl-1,3-dioxolo[4,5- g]isoquinolin-5-yl]-1(3H)-isobenzofuranone
• Androst-4-en-3-one,17-hydroxy-,(17â)-,mixt. with 3,7-dihydro-7-(2-hydroxyethyl)-1,- 3-dimethyl-1H-purine-2,6-dione,3,7-dihydro-1,3,7-trimethyl-1H-purine-2,6- dione,(17â)-10-ethyl-17-hydroxyestr-4-en- 3-one,4-hydroxy-R-[1-[(1-methyl-3-phenylpropyl) amino]ethyl]benzenemethanol hydrochloride and (17R)-19-norpregna-1,3,5(10)-trien-20-yne- 3,17-diol
• Androst-4-en-3-one,17-hydroxy-,(17â)-,mixt. with 3,7-dihydro-7-(2-hydroxyethyl)-1,- 3-dimethyl-1H-purine-2,6-dione,3,7-dihydro-1,3,7-trimethyl-1H-purine-2,6- dione,(17â)-10-ethyl-17-hydroxyestr-4-en- 3-one,4-hydroxy-R-[1-[(1-methyl-3-phenylpropyl) amino]ethyl]benzenemethanol hydrochloride and (17R)-19-norpregna-1,3,5(10)-trien-20-yne- 3,17-diol
• Morphinan-6-ol,7,8-didehydro-4,5-epoxy-3- methoxy-17-methyl-,(5R,6R)-,phosphate (1:1) (salt),mixt. with (3-endo)-8-methyl-8-azabicyclo[3.2.1]oct-3- yl R-(hydroxymethyl)benzeneacetate sulfate (2:1) (salt),sodium [(2,3-dihydro-1,5-dimethyl-3- oxo-2-phenyl-1H-pyrazol-4-yl)methylamino]- methanesulfonate and N,N,R-trimethyl-10H-phenothiazine-10- ethanamine monohydrochloride
• Morphinan-6-ol, 4,5-epoxy-3-methoxy-17-methyl-, (5-alpha,6-alpha)-, phosphate (1:1) (salt), mixt. with (R-(R*,S*))-alpha-(1-(methylamino)ethyl)benzenemethanol hydrochloride
• â-D-Glucopyranoside,(1S,2R,3R,4R)-2-[(3â,4â,- 5R,17â)-3-[(O-6-deoxy-R-Lmannopyranosyl-( 1f2)-O-[6-deoxy-R-Lmannopyranosyl-( 1f6)]-â-D-glucopyranosyl)- oxy]-4-(hydroxymethyl)-4,14-dimethyl-9,19- cycloandrostan-17-yl]-3-hydroxy-4-(1- hydroxy-1-methylethyl)cyclopentyl O-â-D-glucopyranosyl-(1f2)-O-[â-Dxylopyranosyl-( 1f6)]-
• 2H-Pyran-2-acetic acid,6-[(1R)-1-[(2S,5R,7S,8R,9S)-2-[(2S,- 2'R,3'S,5R,5'R)-3'-[(2,6-dideoxy-3,4-di-Omethyl- â-L-arabino-hexopyranosyl)oxy]- octahydro-2-methyl-5'-[(2S,3S,5R,6S)-tetrahydro- 6-methoxy-3,5,6-trimethyl-2H-pyran- 2-yl][2,2'-bifuran]-5-yl]-9-hydroxy-2,8- dimethyl-1,6-dioxaspiro[4.5]dec-7-yl]ethyl]- tetrahydro-2-hydroxy-4,5-dimethoxy-3- methyl-,(2R,3S,4S,5R,6S)-
• (1α,2β,4β,5α,7β)-()-9-methyl-3-oxa-9-azatricyclo[3.3.1.02,4]non-7-yl (hydroxymethyl)phenylacetate hydrochloride
• 18-Norandrostane-4-propanoic acid,13-carboxy-â,6-dihydroxy-4,9- dimethyl-3,15-bis(1-methylethenyl)-,Elactone,(âR,3R,4â,5â,6â,8R,9â,10R,13R,14â,15â,- 17â)-
• â-D-Glucopyranoside,(3â,7â,9â,10R,16â)-7- hydroxy-9-methyl-3-(â-D-xylopyranosyloxy)- 19-norlanosta-5,24-dien-16-yl,4-acetate
• 5-oxo-L-proline, compound with [7(S)-(1α,2β,4β,5α,7β)]-9-methyl-3-oxa-9-azatricyclo[3.3.1.02,4]non-7-yl α-(hydroxymethyl)benzeneacetate (1:1)